Why Anti-Dandruff Shampoo Cannot Use a Cosmetic Notification

A maker reached out convinced her anti-dandruff shampoo just needed a Cosmetic Notification Form like the rest of her hair care line. It does not, and the reason has nothing to do with paperwork and everything to do with what the product claims to do.

The claim is what moves the product, not the ingredient alone

Here is the mechanism worth understanding clearly: adding zinc pyrithione to a shampoo does not by itself make the product a drug. What makes it a drug is combining that ingredient with a therapeutic claim, treating, controlling, or reducing dandruff as a condition, rather than just cleansing hair and scalp. A shampoo that simply cleanses is a cosmetic. A shampoo that treats a scalp condition is functioning as a drug, and that is the line regulators draw across most markets, not just Canada.

This same pattern shows up elsewhere in personal care. Sunscreen, anti-acne treatments, antiperspirants, and fluoride toothpaste all follow the identical logic: a cosmetic claim (moisturizing, cleansing, softening) keeps a product in cosmetic territory, while a therapeutic claim (treats, prevents, reduces a medical condition) pushes it into drug regulation, generally with a much heavier evidentiary and approval burden attached.

Why this trips up so many small brands

It is an easy mistake because the finished product looks and behaves exactly like a regular shampoo. Same bottle, same surfactant base, same use pattern in the shower. Nothing about the physical product screams "this is regulated differently." The distinction lives entirely in the ingredient-plus-claim combination, which is invisible on the shelf and only becomes obvious when you read the actual label language or marketing copy next to the ingredient list.

A maker who adds a small percentage of zinc pyrithione "for scalp health" and writes "helps reduce flaking associated with dandruff" on the label has, in that sentence, moved the product out of the cosmetic notification pathway. The same base shampoo formula, sold with a claim like "gently cleanses scalp and hair," stays a cosmetic and follows the standard CNF path.

What actually happens instead of a CNF

Once a product crosses into drug territory because of an active ingredient and a therapeutic claim, it is regulated under an entirely different framework, with its own approval, monograph, or licensing requirements depending on the market and the specific active involved. This is a heavier lift than a cosmetic notification: cosmetic notification is exactly that, a notification, not pre-market approval, while drug pathways typically involve actual review before you can sell.

This is not something to route around with a Cosmetic Notification Form. Filing a CNF for a product that is functioning as a drug does not make it compliant, it just means you have the wrong filing on record for what you are actually selling.

A quick self-check before you formulate

If you are building or already selling a scalp product, ask yourself two questions honestly:

• Does the formula contain an ingredient historically associated with therapeutic scalp or skin treatment (zinc pyrithione, salicylic acid at treatment concentrations, coal tar, ketoconazole, selenium sulfide) at a level meant to have a treatment effect?
• Does the label, packaging, or marketing copy claim to treat, control, reduce, or prevent a named condition like dandruff, as opposed to describing a cosmetic benefit like cleansing or conditioning?

A yes to both generally means you are in drug territory, not cosmetic notification territory, and need to have that conversation with a regulatory professional who handles drug submissions specifically, well before you print labels or take your first sale.

Staying on the cosmetic side, if that is your intent

If your goal is to stay squarely in cosmetic territory, keep both the ingredient and the claim inside cosmetic norms. A gentle, clarifying shampoo that happens to help with a flaky scalp through moisturizing and exfoliating cosmetic ingredients, described only in cosmetic language, can often stay on the CNF pathway. The moment either the active ingredient or the claim language crosses into therapeutic territory, that pathway closes.

Cosmetic Comply is built for the cosmetic side of this line, mapping ingredients to INCI and CAS, screening against the Hotlist, and filing your CNF once you are confident your product and its claims genuinely sit in cosmetic territory rather than drug territory.